Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver Cancer

Table 2

CEP55 expression associated with clinical pathological characteristics (logistic regression).

Clinical characteristics	Total ()	Odds ratio in CEP55 expression	value
Age (≥65 vs.<65)	370	1.76 (1.16-2.69)	0.008
Gender (female vs. male)	404	0.64 (0.43-0.97)	0.037
Stage (I/II vs. III/IV)	380	1.97 (1.23-3.19)	0.005
Histological grade (G1/G2 vs. G3/G4)	366	3.06 (1.97-4.81)	9.08-7
T (T1/T2 vs. T3/T4)	415	1.95 (1.23-3.12)	0.005
N (N0 vs. N1)	285	7.36 (1.29-138.56)	0.063
M (M0 vs. M1)	300	1.34 (029-0.91)	0.703
Survival status (alive vs. dead)	404	1.77 (1.17-2.68)	0.007
Histological type (HCC vs. CCA)	404	18.13 (5.38-112.99)	8.43-5

Bold values indicate statistical significance. Abbreviations: HCC: hepatocellular carcinoma; CCA: cholangiocarcinoma.